A Multi-center, Randomized, Double-blind Study to Compare the Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Latest Information Update: 15 Jun 2020
At a glance
- Drugs Cadazolid (Primary) ; Vancomycin
- Indications Clostridium difficile infections
- Focus Registrational; Therapeutic Use
- Acronyms IMPACT 1
- Sponsors Actelion Pharmaceuticals
- 24 Apr 2018 Results from IMPACT 1 and IMPACT 2 studies, presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases
- 19 Apr 2017 Status changed from active, no longer recruiting to completed.
- 28 Feb 2017 Planned End Date changed from 1 Feb 2017 to 1 Mar 2017.